[Clinical efficacy of using ximedon in surgical practice].
Results of clinical trial of the new pyrimidine derivative--ximedone are presented. The drug was administered per os 0.5 g x 4 times a day (0.5 h before meals). Total course dose achieved 60 g. Ximedone implementation for complex treatment of burns, trophic ulcer of lower limbs, different inflammations demonstrated positive results. Prophylaxy administration of the drug in abdominal surgery at acute appendix resulted with lower incidence of postoperative complications. High efficacy and good tolerability of the drug allows to recommend it for wide medical use.
Izmaĭlov
S G
SG
Military Medical Institute, Kazan State Medical University, Respublican Clinical Hospitals No. 1, No. 5, No. 7, Septic Center, Kazan.
Izmaĭlov
G A
GA
Zaikonnikova
I V
IV
Reznik
V S
VS
Tereshchenko
V Iu
VIu
Gorbunov
S M
SM
Evranova
G V
GV
Shaĭmardanov
R Sh
RSh
Muslinkin
A A
AA
Bodrov
A A
AA
Abdulkhakov
R A
RA
Lazarev
V M
VM
Kedrin
M Iu
MIu
Gurylev
E A
EA
Mavziutov
L Kh
LKh
Mavziutov
L Kh
LKh
Malyshev
K V
KV
Gabbasov
R N
RN
Shafikov
I Z
IZ
Kochnev
O S
OS
Podushkina
I V
IV
Izmaĭlov
A G
AG
Garaev
V N
VN
Sharafislamov
I F
IF
Gerasimova
M Kh
MKh
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis; D002056:Burns / Q000188:drug therapy; D006801:Humans; D011743:Pyrimidines / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D011743:Pyrimidines; C069705:xymedon